Alibaba Health Information Technology Limited
Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. The company offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, healthcare food, adult and famil… Read more
Alibaba Health Information Technology Limited (ALBBY) - Total Liabilities
Latest total liabilities as of September 2025: $5.70 Billion USD
Based on the latest financial reports, Alibaba Health Information Technology Limited (ALBBY) has total liabilities worth $5.70 Billion USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Alibaba Health Information Technology Limited - Total Liabilities Trend (2004–2025)
This chart illustrates how Alibaba Health Information Technology Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Alibaba Health Information Technology Limited Competitors by Total Liabilities
The table below lists competitors of Alibaba Health Information Technology Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Renaissancere Holdings Ltd
NYSE:RNR
|
USA | $34.59 Billion |
|
Hon. Precision, Inc.
TW:7769
|
Taiwan | NT$17.68 Billion |
|
Informa plc
PINK:IFPJF
|
USA | $6.46 Billion |
|
A.P. Møller - Mærsk A/S
PINK:AMKBF
|
USA | $31.66 Billion |
|
Roku Inc
NASDAQ:ROKU
|
USA | $1.78 Billion |
|
WESCO International Inc
NYSE:WCC
|
USA | $11.47 Billion |
|
Verona Pharma plc
F:I9SA
|
Germany | €294.60 Million |
Liability Composition Analysis (2004–2025)
This chart breaks down Alibaba Health Information Technology Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.71 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.32 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.24 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Alibaba Health Information Technology Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Alibaba Health Information Technology Limited (2004–2025)
The table below shows the annual total liabilities of Alibaba Health Information Technology Limited from 2004 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | $4.87 Billion | -6.22% |
| 2024-03-31 | $5.19 Billion | -7.37% |
| 2023-03-31 | $5.60 Billion | +9.17% |
| 2022-03-31 | $5.13 Billion | +48.36% |
| 2021-03-31 | $3.46 Billion | +29.62% |
| 2020-03-31 | $2.67 Billion | -17.80% |
| 2019-03-31 | $3.25 Billion | +451.96% |
| 2018-03-31 | $587.92 Million | +4.98% |
| 2017-03-31 | $560.04 Million | +190.36% |
| 2016-03-31 | $192.88 Million | +35.99% |
| 2015-03-31 | $141.83 Million | +70.14% |
| 2014-03-31 | $83.36 Million | -38.80% |
| 2013-03-31 | $136.20 Million | +21.01% |
| 2012-03-31 | $112.56 Million | -18.34% |
| 2011-03-31 | $137.84 Million | +5.91% |
| 2010-03-31 | $130.15 Million | +12.68% |
| 2009-03-31 | $115.51 Million | -33.53% |
| 2008-03-31 | $173.78 Million | -71.86% |
| 2007-03-31 | $617.60 Million | -10.25% |
| 2006-03-31 | $688.15 Million | +387.30% |
| 2005-03-31 | $141.22 Million | -21.08% |
| 2004-03-31 | $178.94 Million | -- |